HLB Pharmaceutical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Cash & Equivalents	7,609	10,492	2,744	3,030	5,350
Short-Term Investments	14,528	11,500	1,310	235	525
Trading Asset Securities	-	-	11,109	5,842	5,514
Cash & Short-Term Investments	22,137	21,992	15,163	9,107	11,389
Cash Growth	0.66%	45.04%	66.50%	-20.04%	-
Accounts Receivable	22,833	16,095	7,910	6,044	6,382
Other Receivables	1,395	1,408	156.15	163.97	128.86
Receivables	24,227	17,504	8,066	6,218	6,521
Inventory	29,526	22,861	5,648	5,382	4,884
Prepaid Expenses	151.11	178.25	47.26	428.26	242.13
Other Current Assets	660.69	845.65	93.85	140.41	230.82
Total Current Assets	76,702	63,381	29,018	21,275	23,267
Property, Plant & Equipment	44,388	34,020	15,315	13,304	13,323
Long-Term Investments	45,204	55,078	146.5	1,265	1,789
Goodwill	105.07	-	-	-	-
Other Intangible Assets	3,670	4,448	446.2	282.13	188.45
Long-Term Deferred Tax Assets	-	-	208.27	6.99	1,002
Long-Term Deferred Charges	185.53	387.79	629.76	129.67	-
Other Long-Term Assets	428.28	620.27	82.12	160.27	277.32
Total Assets	170,682	157,933	45,846	36,423	39,846
Accounts Payable	10,257	8,718	2,404	4,856	2,261
Accrued Expenses	6,619	8,133	4,593	2,092	2,241
Short-Term Debt	15,000	15,000	8,458	4,854	1,725
Current Portion of Long-Term Debt	-	-	780	1,580	10,388
Current Portion of Leases	1,540	763.8	426.67	-	-
Current Income Taxes Payable	-	-	-	105.9	-
Other Current Liabilities	6,212	6,017	6,429	2,736	1,126
Total Current Liabilities	39,628	38,632	23,092	16,224	17,741
Long-Term Debt	-	-	1,580	1,260	2,840
Long-Term Leases	4,144	290.77	1,954	-	-
Pension & Post-Retirement Benefits	1,436	937.15	1,166	1,521	2,375
Long-Term Deferred Tax Liabilities	325.35	1,672	-	314.93	-
Other Long-Term Liabilities	0	0	151.41	105.72	88.99
Total Liabilities	45,534	41,532	27,943	19,425	23,045
Common Stock	16,400	15,907	6,924	6,924	6,247
Additional Paid-In Capital	61,981	93,433	8,435	17,304	15,263
Retained Earnings	56,368	1,971	1,215	-8,453	-5,410
Treasury Stock	-5.6	-5.6	-5.6	-5.6	-5.6
Comprehensive Income & Other	-9,594	5,096	1,334	1,229	707.13
Shareholders' Equity	125,149	116,402	17,903	16,998	16,802
Total Liabilities & Equity	170,682	157,933	45,846	36,423	39,846
Total Debt	20,684	16,055	13,198	7,694	14,953
Net Cash (Debt)	1,453	5,938	1,965	1,413	-3,564
Net Cash Growth	-75.53%	202.18%	39.05%	-	-
Net Cash Per Share	44.49	185.20	141.88	104.39	-297.72
Filing Date Shares Outstanding	32.68	31.81	13.85	13.85	12.49
Total Common Shares Outstanding	32.68	31.81	13.85	13.85	12.49
Working Capital	37,073	24,749	5,927	5,052	5,526
Book Value Per Share	3829.94	3658.77	1292.83	1227.52	1344.92
Tangible Book Value	121,374	111,954	17,457	16,716	16,613
Tangible Book Value Per Share	3714.43	3518.98	1260.61	1207.15	1329.84
Land	26,792	26,792	1,239	1,239	1,239
Buildings	3,697	3,697	8,520	8,472	8,581
Machinery	15,616	15,770	9,673	8,772	9,892
Construction In Progress	6,523	1,658	382.9	183.6	136.94

Source: S&P Global Market Intelligence. Standard template. Financial Sources.